TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17072741

Group type: EXPERIMENTAL
Intervention: Tennis playing (young players)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tennis playing (adult players)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tennis playing (adults)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tennis playing (children)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tennis playing (long-term)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tennis playing (impact-loading sports)
Number of subjects: 70
Study: 15501412

Group type: EXPERIMENTAL
Intervention: HES+albumin
Number of subjects: 42

Group type: COMPARATOR
Intervention: albumin
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: group 2 (not specified in the abstract)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: group 3 (albumin)
Number of subjects: 42
Study: 10674563

Group type: EXPERIMENTAL
Intervention: Cord blood IgE
Number of subjects: 64
Study: 9279891

Group type: EXPERIMENTAL
Intervention: Radiolabelled pessary formulation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Replens (polycarbophil) gel
Number of subjects: 6
Study: 8352327

Group type: EXPERIMENTAL
Intervention: Young adult women
Number of subjects: 40

Group type: COMPARATOR
Intervention: Older adult women
Number of subjects: 40
Study: 30985171

Group type: EXPERIMENTAL
Intervention: Pleasant olfactory cues
Number of subjects: 232

Group type: COMPARATOR
Intervention: Odor blank (neutral)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Tobacco-related olfactory cues
Number of subjects: 232
Study: 28528227

Group type: EXPERIMENTAL
Intervention: Integrated care condition
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 182
Study: 26681703

Group type: EXPERIMENTAL
Intervention: Radio campaign focused on child health, broadcast from March 2012 to January 2015.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short radio spots as part of the campaign.
Number of subjects: 0
Study: 23702236

Group type: EXPERIMENTAL
Intervention: Speech therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of CPAP and speech therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (sham speech therapy)
Number of subjects: 100
Study: 20943717

Group type: EXPERIMENTAL
Intervention: Exercise training (group A)
Number of subjects: 25
Study: 18066631

Group type: EXPERIMENTAL
Intervention: Usual care plus choice of chiropractic, acupuncture, or massage
Number of subjects: 444

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 444
Study: 16420253

Group type: EXPERIMENTAL
Intervention: Trizivir (TZV) twice daily (n = 85)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Combivir/nelfinavir (COM/NFV) 1250 mg twice daily (n = 88)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Stavudine/lamivudine/nelfinavir (d4T/3TC/NFV) 40 mg+150 mg+1250 mg twice daily (n = 81)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Trizivir (TZV)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Combivir/nelfinavir (COM/NFV) and Stavudine/lamivudine/nelfinavir (d4T/3TC/NFV)
Number of subjects: 254
Study: 12562722

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg nightly for 7 days before IOS dose
Number of subjects: 15

Group type: COMPARATOR
Intervention: Itraconazole oral solution (IOS) 400 mg
Number of subjects: 15
Study: 11059872

Group type: EXPERIMENTAL
Intervention: Combination therapy for 12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon for 12 months
Number of subjects: 0
Study: 9107581

Group type: EXPERIMENTAL
Intervention: Transmitted digital images
Number of subjects: 26

Group type: COMPARATOR
Intervention: Plain radiographs (KUB)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Comparison of plain film and digital image interpretations
Number of subjects: 26
Study: 8473720

Group type: EXPERIMENTAL
Intervention: moclobemide 200 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: moclobemide 400 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: amitriptyline 50 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 3513744

Group type: EXPERIMENTAL
Intervention: 1.0% suprofen
Number of subjects: 412

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 412
Study: 28814128

Group type: EXPERIMENTAL
Intervention: Telehealth intervention (diabetes program)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 126
Study: 27508319

Group type: EXPERIMENTAL
Intervention: fat-modified diet plus cholestyramine (8 g twice daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 26
Study: 24797765

Group type: EXPERIMENTAL
Intervention: Additional educational material (SAGA tool)
Number of subjects: 773

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Additional educational material (SAGA tool) in treatment-naïve patients
Number of subjects: 773

Group type: COMPARATOR
Intervention: Standard treatment in treatment-naïve patients
Number of subjects: 773
Study: 21685814

Group type: EXPERIMENTAL
Intervention: Intrahospital combined circuit weight and aerobic training program
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 22
Study: 21036034

Group type: EXPERIMENTAL
Intervention: Biennial mammographic screening
Number of subjects: 1360
Study: 18265446

Group type: EXPERIMENTAL
Intervention: New platelet products using platelet additive solutions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard platelet transfusion practices
Number of subjects: 0
Study: 14759085

Group type: EXPERIMENTAL
Intervention: Warfarin plus 100 mg/day ASA (group A, n = 70)
Number of subjects: 140

Group type: COMPARATOR
Intervention: 100 mg/day ASA alone (group B, n = 70)
Number of subjects: 140
Study: 11691649

Group type: EXPERIMENTAL
Intervention: Hypo-energetic diet (6 weeks, week 0-6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Iso-energetic diet (4 weeks, week 6-10)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hypo-energetic diet (6 weeks, week 10-16)
Number of subjects: 12
Study: 9338539

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate powder (250 microg twice daily)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Triamcinolone acetonide aerosol (200 microg four times daily)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 8081133

Group type: EXPERIMENTAL
Intervention: Continuous professional support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early amniotomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early use of oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination of early amniotomy and early oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Strict diagnostic criteria for labour
Number of subjects: 0
Study: 3652705

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) synchronized with the cardiac cycle (sync)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-frequency jet ventilation (HFJV) nonsynchronized with the cardiac cycle (async)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) synchronized at sync 0
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) synchronized at sync 60
Number of subjects: 10
Study: 30953543

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (1.5 g), thiamine (100 mg), and hydrocortisone (50 mg) every 6 hours until 16 administrations or ICU discharge.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebos until a total of 16 administrations have been completed or ICU discharge occurs.
Number of subjects: 0
Study: 30317013

Group type: EXPERIMENTAL
Intervention: High speed resistance training (HSRT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High speed resistance training plus balance exercises (HSRTB)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 27829367

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg IN ketamine
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.1 mg/kg IV morphine
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.15 mg/kg IM morphine
Number of subjects: 90
Study: 24128184

Group type: EXPERIMENTAL
Intervention: Affective forecasting
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Attention diversion from probability specifications
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Attention drawn toward probability specifications
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: More affectively intense forecasted outcome
Number of subjects: 6
Study: 22314136

Group type: EXPERIMENTAL
Intervention: Measles vaccine at 4 months of age
Number of subjects: 0

Group type: COMPARATOR
Intervention: Measles vaccine at 9 months of age (group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Booster at 36 months of age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Re-vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: At 48 months of age (group 2)
Number of subjects: 0
Study: 19155117

Group type: EXPERIMENTAL
Intervention: Simulator training with force feedback
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no force feedback)
Number of subjects: 101
Study: 17472324

Group type: EXPERIMENTAL
Intervention: Neuromuscular training program (15 minutes duration, three balance exercises)
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Neuromuscular training program (for compliers)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Control season
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Compliance with the program
Number of subjects: 850
Study: 15940126

Group type: EXPERIMENTAL
Intervention: Inhalation of 50 microg LPS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Oral methylprednisolone 20 mg/d for 6 days
Number of subjects: 15
Study: 11752998

Group type: EXPERIMENTAL
Intervention: Intrathecal adenosine (2 mg)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Intrathecal adenosine (0.25-2.0 mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 10912983

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 400 microg
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Oral misoprostol 400 microg
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Laminaria
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 106
Study: 7740420

Group type: EXPERIMENTAL
Intervention: Repeated sclerotherapy (n = 21)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Interposition mesocaval shunt (n = 24)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 45
Study: 2390255

Group type: COMPARATOR
Intervention: Thiopental sodium by infusion throughout CPB (n = 52)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Thiopental sodium 15 mg/kg by bolus before aortic declamping (n = 48)
Number of subjects: 100
Study: 6115596

Group type: COMPARATOR
Intervention: Morphine + Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morphine + Cimetidine (H2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morphine + Diphenhydramine (H1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morphine + Cimetidine (H2) + Diphenhydramine (H1)
Number of subjects: 40
Study: 31464063

Group type: EXPERIMENTAL
Intervention: Faster insulin aspart
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard insulin aspart
Number of subjects: 15
Study: 28216232

Group type: EXPERIMENTAL
Intervention: BIIB074 150 mg three times per day for 21 days, followed by random assignment to BIIB074 or placebo for up to 28 days.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo for up to 28 days after open-label phase.
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: BIIB074
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 25552403

Group type: EXPERIMENTAL
Intervention: 850 mg metformin hydrochloride administered p.o. in the evening of day 4 and in the morning of day 5
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 200 mg trimethoprim administered p.o. twice daily for 5 days
Number of subjects: 12
Study: 23967069

Group type: EXPERIMENTAL
Intervention: CyberSenga online healthy sexuality program (5-hour duration)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: CyberSenga with booster (4 months post-intervention)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Treatment as usual (school-delivered sexuality programming)
Number of subjects: 366
Study: 22104634

Group type: EXPERIMENTAL
Intervention: RLAI+TAU
Number of subjects: 45

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 45
Study: 19930513

Group type: EXPERIMENTAL
Intervention: Erroneous examples with elaborated feedback
Number of subjects: 124

Group type: COMPARATOR
Intervention: Erroneous examples with KCR feedback
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Conditions with elaborated feedback
Number of subjects: 124
Study: 17942872

Group type: EXPERIMENTAL
Intervention: HPV test plus Pap test
Number of subjects: 12527

Group type: COMPARATOR
Intervention: Pap test alone
Number of subjects: 12527
Study: 15365225

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paroxetine (PAROX)
Number of subjects: 80
Study: 11493503

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 38
Study: 9830640

Group type: EXPERIMENTAL
Intervention: Maxillary and mandibular nerve blocks (n = 7)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-block group (without nerve blocks; n = 7)
Number of subjects: 14
Study: 10155523

Group type: EXPERIMENTAL
Intervention: Interactive videodisc (IVD) instruction for 8 hours covering five subject areas: airway, head/cervical trauma, chest, shock, cardiac arrest.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Pre-IVD group (baseline)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Post-IVD group
Number of subjects: 150
Study: 2241347

Group type: EXPERIMENTAL
Intervention: Cephalothin
Number of subjects: 450

Group type: COMPARATOR
Intervention: Cefamandole
Number of subjects: 450
Study: 679592

Group type: EXPERIMENTAL
Intervention: Phase I drug testing program
Number of subjects: 29162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29162
Study: 30723321

Group type: EXPERIMENTAL
Intervention: Migalastat
Number of subjects: 14
Study: 28068780

Group type: EXPERIMENTAL
Intervention: Naltrexone-assisted detoxification
Number of subjects: 150

Group type: COMPARATOR
Intervention: Buprenorphine-assisted detoxification
Number of subjects: 150
Study: 26780390

Group type: EXPERIMENTAL
Intervention: Dyspeptic patients
Number of subjects: 106
Study: 22427020

Group type: EXPERIMENTAL
Intervention: Caffeine (2 mg/kg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Caffeine (1 mg/kg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 21269041

Group type: EXPERIMENTAL
Intervention: Colgate Total Toothpaste (0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% sodium fluoride)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Crest Pro-Health Toothpaste (0.454% stannous fluoride, sodium hexametaphosphate, zinc lactate)
Number of subjects: 109
Study: 18427773

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 117

Group type: COMPARATOR
Intervention: Alendronate, vitamin D, and calcium (Control Group)
Number of subjects: 117
Study: 15990753

Group type: EXPERIMENTAL
Intervention: Carbonized MAC stent
Number of subjects: 396

Group type: COMPARATOR
Intervention: High-grade stainless steel MAC stent
Number of subjects: 396
Study: 14595299

Group type: EXPERIMENTAL
Intervention: Curved array echoendoscopy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Radial echoendoscopy
Number of subjects: 104
Study: 10385127

Group type: EXPERIMENTAL
Intervention: Dorzolamide
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8889673

Group type: EXPERIMENTAL
Intervention: Intranasal heroin (6 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intranasal heroin (12 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intramuscular heroin (6 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Detection times for total morphine by GC‐MS and immunoassay (300‐ng/mL cutoff concentration)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 6‐Acetylmorphine concentrations
Number of subjects: 6
Study: 1988535

Group type: COMPARATOR
Intervention: PCA with morphine sulfate (MS) alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PCA plus continuous infusion of morphine sulfate (PCA + CI)
Number of subjects: 30
Study: 6297417

Group type: EXPERIMENTAL
Intervention: Continuous suture technique
Number of subjects: 571

Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 571
Study: 30451329

Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29891957

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy and behaviour change counselling
Number of subjects: 800

Group type: COMPARATOR
Intervention: Counselling alone
Number of subjects: 800
Study: 26823037

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (basic therapies only)
Number of subjects: 0
Study: 25190744

Group type: EXPERIMENTAL
Intervention: High-Intensity Concurrent Training (HICT) consisting of two weekly sessions of speed endurance training (SET) followed by heavy resistance training (HRT) and two weekly sessions of aerobic training
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High-Intensity Concurrent Training (HICT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CON) maintaining their training
Number of subjects: 23
Study: 22355384

Group type: EXPERIMENTAL
Intervention: Helmet only
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Helmet and information
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Information only
Number of subjects: 1557

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1557
Study: 21174291

Group type: EXPERIMENTAL
Intervention: Preoperative intra-aortic balloon pump (IABP) support
Number of subjects: 502

Group type: COMPARATOR
Intervention: Control group with no preoperative IABP
Number of subjects: 502
Study: 17537771

Group type: EXPERIMENTAL
Intervention: Diagnostic polysomnography night
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CPAP titration night
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 16765148

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 480

Group type: COMPARATOR
Intervention: Nicotine nasal spray
Number of subjects: 480
Study: 15255784

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (960 micro g d(‐1), 3 months)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 10627331

Group type: EXPERIMENTAL
Intervention: Back propagation neural network
Number of subjects: 2

Group type: COMPARATOR
Intervention: Statistical method
Number of subjects: 2
Study: 9014483

Group type: EXPERIMENTAL
Intervention: Beni-koji aqueous extracts (27 g of beni-koji eq. per day) for 8 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Vehicle (apple juice)
Number of subjects: 29
Study: 1551349

Group type: EXPERIMENTAL
Intervention: Metoclopramide (40 mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Domperidone (80 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3924720

Group type: EXPERIMENTAL
Intervention: Intravenous nutritional repletion with dextrose providing 0.95 times baseline resting energy expenditure
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous nutritional repletion with dextrose providing 1.75 times baseline resting energy expenditure
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nutritional repletion for 7 days
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nutritional repletion for an additional 8 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Baseline period with 5% dextrose, 440 kcal per day
Number of subjects: 6
Study: 31535628

Group type: EXPERIMENTAL
Intervention: Testicular volume measurement
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: BMI and LH in multivariable model
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: IIEF-5 score
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Handgrip strength and physical function tests
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: AMS score
Number of subjects: 89
Study: 30448186

Group type: EXPERIMENTAL
Intervention: Innovative method (rotational scarf osteotomy with bone fragment impaction and adductor hallucis tendon reinsertion)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard method (classical scarf osteotomy)
Number of subjects: 78
Study: 28803380

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic interval training (AIT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Non-training control (CONT)
Number of subjects: 38
Study: 26495416

Group type: EXPERIMENTAL
Intervention: R-acupuncture group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NR-acupuncture group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pooled-acupuncture group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 23383969

Group type: EXPERIMENTAL
Intervention: Ultrasound with hyaluronidase
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ultrasound without hyaluronidase
Number of subjects: 42
Study: 21729485

Group type: EXPERIMENTAL
Intervention: Child-oriented dietary intervention
Number of subjects: 660
Study: 19346114

Group type: EXPERIMENTAL
Intervention: Betaine-rich diet (approximately 800 mg/day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Betaine supplement (0.5 g twice daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (pre-treatment values)
Number of subjects: 8
Study: 17595426

Group type: EXPERIMENTAL
Intervention: Home Environmental Skill‐Building Program
Number of subjects: 105
Study: 15224241

Group type: COMPARATOR
Intervention: Vegetarians
Number of subjects: 10550

Group type: EXPERIMENTAL
Intervention: General population
Number of subjects: 10550

Group type: COMPARATOR
Intervention: Young adulthood vegetarians
Number of subjects: 10550